Live Breaking News & Updates on Ncluding The Recently Approved Percept Pc Neurostimulator This System Will Enhance Detection Of Local Field Potentials Lfps Which Are 1 Million Times Smaller Than Dbs Stimulation Pulses And Offers Directional To Provide Individualized Patient Specific Data As Well Additional Programming Features Tailor Therapy For Patients 2 Story Is Provided By Businesswire India Ani Not Be Responsible In Any Way Content Article

Mumbai (Maharashtra) [India], August 25 (ANI/BusinessWire India): Medtronic Private Limited, a wholly-owned subsidiary of Medtronic plc, today announced the launch of SenSight directional lead system for Deep Brain Stimulation (DBS) therapy as treatment of symptoms associated with movement disorders and epilepsy. Deep brain stimulation (DBS) is a treatment for symptoms of Parkinson's disease, including tremors, stiffness, and trouble walking. Parkinson's disease is a progressive disorder that eventually causes severe disability due to the increasing severity of treatment-resistant motor problems and non-motor symptoms In 2016, it was estimated that 6.1 million people worldwide had Parkinson's disease. The prevalence in India was estimated to be 10 per cent of the global burden, that is, 5.8 lakhs.1 DBS is a therapy in which a small pacemaker-like device sends electrical signals through very thin wires, known as 'leads' to a targeted area in the brain related to the ....

Ravi Gopal Varma , Rahul Arora , Medtronic Private , Global Center , Businesswire India , Medtronic Private Limited , Deep Brain Stimulation , Aster Hospitals , Lead Consultant Neurosurgeon , Movement Disorders Specialist , Neurosciences Therapies , Mumbai Maharashtra India , Ugust 25 Ani Businesswire India Medtronic Private Limited , A Wholly Owned Subsidiary Of Medtronic Plc , Oday Announced The Launch Of Sensight Directional Lead System For Deep Brain Stimulation Dbs Therapy As Treatment Symptoms Associated With Movement Disorders And Epilepsy Isa Parkinson 39s Disease , Ncluding Tremors , Nd Trouble Walking Parkinson 39s Disease Isa Progressive Disorder That Eventually Causes Severe Disability Due To The Increasing Severity Of Treatment Resistant Motor Problems And Non Symptoms In 2016 , T Was Estimated That 6 1 Million People Worldwide Had Parkinson 39s Disease The Prevalence In India To Be 10 Per Cent Of Global Burden , What Is , Nown As 39 Leads Toa Targeted Area In The Brain Related To Symptoms Sensight Directional Lead Systems Were First Recently Implanted India By Multi Disciplinary Teams From Aster Hospitals Bangalore Comprising Of Dr Ravi Gopal Varma Director Global Center Excellence Neurosciences Amp Consultant Neurosurgeon , R Mirza Masoom Abbas Neurologist Amp Movement Disorders Specialist And Dr Nirmalas Consultant Neurosurgeon This Was Implanted Ina 60 Yr Old Male Patient Suffering From Symptoms Of Parkinson 39s Disease For Last 8 9 Years Quot Is The Only Directional Lead Device Designed Sensing That May Aid In Increasing Stimulation Precision , Uot Said Dr Ravi Gopal Varma , Uot The Directional Leads Have Segmented Electrodes That Help To Target Stimulation In Desired Areas Of Brain Each Electrode Can Be Programmed Optimize Patient Outcomes And Reduce Induced Side Effects Sensight Is First Only Dbs Lead System Offers Directionality Sensing Synergies This Coupling Looks Promising For Parkinson 39s Patients Quot Disease Isa Progressive Disorder Eventually Causes Severe Disability Medtronic Has Always Been Committed Offering Latest Advancements Management Other Movement Disorders Improve 39 Quality Life With Introduction Our Country , E Are Confident About Further Improving Patient Experiences And Clinical Outcomes With Such Disorders Quot Said Rahul Arora , Neurosciences Therapies , Edtronic India With Collaboration And Insights From Clinicians ,